Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds

Journal of Infectious Diseases

Volumn 169, Issue 5, 1994, Pages 1007-1013

  Proud, David ^a,b,c,d   Gwaltney, Jack M ^a,b,c,d   Hendley, J Owen ^a,b,c,d   Dinarello, Charles A ^a,b,c,d   Gillis, Steven ^a,b,c,d   Schleimer, Robert P ^a,b,c,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c TUFTS UNIVERSITY   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PREDNISONE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HUMAN; HUMAN EXPERIMENT; INTRANASAL DRUG ADMINISTRATION; NORMAL HUMAN; NOSE SECRETION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHINITIS; RHINOVIRUS;

ADOLESCENT; ADULT; COMMON COLD; FEMALE; GLUCOCORTICOIDS; HUMAN; INTERLEUKIN-1; MALE; NASAL MUCOSA; RHINOVIRUS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028059073     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.5.1007     Document Type: Article

References (47)

1. Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infection in an industrial population. I. The occurrence ofillness. N Engl J Med 1966;275:1261-8.
2. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1987:157:133-42.
3. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis 1990;161:120-3.
4. Proud D, Reynolds CJ, LaCapra S, Kegey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988; 137:613-6.
5. Doyle WJ, Boehm BS, Skoner DP. Physiologic responses to intranasaldose-response challenges with histamine, methacholine. bradykinin and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol 1990:86:924-35.
6. Rajakulasingam K, Polosa R, Holgate ST, Howarth PH. Comparative nasal effects of bradykinin, kallidin and [des-arg9]-bradykinin in atopic rhinitic and normal volunteers. J Physiol 1991;437:577-87.
7. Auron PE, Webb AC, Rosenwasser LJ, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 1984;81:7907-11.
8. March CJ, Mosley B, Larsen A, et al. Cloning, sequence and expression of two distinct human interleukin-l complementary DNAs. Nature 1985;315:641-7.
9. Kilian PL, Kaflka KL, Stern AS, et al. Interleukin-la and interleukin-10 bind to the same receptor on T-cells. J Immunol 1986:136:4509-14.
10. Oppenheim JJ, Kovacs E, Matsushima L, Durum SK. There is more than one interleukin-1. Immunol Today 1986;7:45-56.
11. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
12. Bevilaqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest 1985;76:2003-11.
13. Schleimer RP, Rutledge BK. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin-1, endotoxin, and tumor-promoting phorbol esters. J Immunol 1986;136:649-54.
14. Farr BM, Gwaltney JM Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162:1173-7.
15. Jackson GG, Dowling HF, Spiesman IG, Board AV. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. Arch Intern Med 1958:101:26778.
16. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983:72:1678-85.
17. Hamparian VV. Rhinoviruses. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures for viral and rickettsial infections. 5th ed. Washington, DC: American Public Health Association, 1979:535-75.
18. Baumgarten CR, Togias AG, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest 1985;76:191-7.
19. Bochner BS, Charlesworth EN, Lichtenstein LM, et al. Interleukin-l is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;86:830-9.
20. Bolton AE, Hunter WM. The labelling of proteins to high specific radioactivities hy conjugation to a l25I-containing acylating agent. Biochem J 1973:133:529-39.
21. Dinarello CA, Ikejima T, Warner SJC, et al. Interleukin-l induces interleukin-1. 1. Induction of circulating interleukin-l in rabbits in vivo and in human mononuclear cells in vitro, J Immunol 1987; 139: 1902-10.
22. Bochner BS, Landy SD, Plaut M, Dinarello CA, Schleimer RP. Interleukin- I production by human lung tissue. I. Identification and characterization. J Immunol 1987;139:2297-302.
23. Dinarello CA. Biology of interleukin 1. FASEB J 1988:2:108-15.
24. Mattoli S, Miante S, Calabro F, Mezzetti M, Fasoli A, Allegra L. Bronchial epithelial cells exposed to isocyanates potentiate activations and proliferation of T-cells. Am J Physiol 1990;259:L320-7.
25. Altman LC, Baker C, Kenney JS, Allison AC. Interleukin synthesis by cultured human nasal epithelial cells [abstract], J Allergy Clin Immunol 1992;89:211.
26. Dinarello CA, Wolt TSM. The role of interleukin-l in disease. N Engl J Med 1993;328:106-13.
27. Winther B, Farr B, Turner RB, Hendley JO, Gwaltney JM Jr, Mygind N. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl (Stockh) 1984;413:19-24.
28. Levandowski RA, Weaver CW, Jackson GG. Nasal-secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J Med Virol 1988:25:323-32.
29. Cavender DE, Haskard DO, Joseph B, Ziff M. Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 1986:136:203-7.
30. Pober JS, Gimbrone M A Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin I. tumor necrosis factor and immune interferon. J Immunol 1986;137:1893-6.
31. Bevilaqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987;84:9238-42.
32. Lobb RR. Integrin-immunoglobulin superfamily interactions in endothelial-leukocyte adhesion. In: Harlan JM, Liu DY, eds. Adhesion: Its role in inflammatory disease New York: WH Freeman, 1992:118.
33. Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 and interleukin-6. Am J RespirCell Mol Biol 1993;8:20-7.
34. Strieter RM, Kunkel SL, Showeil HJ, et al. Endothelial ceil gene expression of a neutrophil chemotactic factor by TNFα, LPS and IL-1β. Science 1989;243:1467-9.
35. Cybulsky MI, McComb DJ, Dinarello CA, Movat HZ. Mediation by interleukin-1 of neutrophil leukocyte emigration induced by endotoxin. In: Movat HZ, ed. Leukocyte emigration and its sequelae. Basel, Switzerland: Karger, 1987:38-50.
36. Bathon JM, Proud D, Krackow K, Wigley FM. Preincubation of human synovial cells with interleukin-1 modulates prostaglandin E2 release in response to bradykinin. J Immunol 1989;143:579-86.
37. Bathon JM, Manning DC, Goldman DW, Towns MC, Proud D. Characterization of kinin receptors on human synovial cells and upregula-tion of receptor number by interleukin-1. J Pharmacol Exp Ther 1992;260:384-92.
38. Martin S, Maruta K, Burkart V, Gillis S, Kold H. IL-1 and IFN-y increase vascular permeability. Immunology 1988;64:301-5.
39. Rossi V, Brevario F, Ghezzi P, Dejana E, Mantovani A. Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 1985;229:174-6.
40. Bussolino F, Brevario F, Tetta C, Aglietta M, Mantovani A, Dejana E. Interleukin-1 stimulates platelet activating factor production in cultured human endothelial cells. J Clin Invest 1986;77:2027-33.
41. Kurt-Jones EA, Virgin HW 4th, Unanue ER. Relationship of macrophage la and membrane IL 1 expression to antigen presentation. J Immunol 1985;135:3652-4.
42. Schleimer RP. Glucocorticoids: Their mechanisms of action and use in allergic disease. In: Middleton E Jr. Reed CE, Eliis EF, Adkinson NF Jr. Yunginger JW. eds. Allergy, principles and practice. 4th ed. St. Louis: CV Mosby, 1992:893-925.
43. Bochner BS, Rutledge BK, Schleimer RP. Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids. J Immunol 1987;139:2303-7.
44. Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J Immunol 1982; 129: 1803-5.
45. Staruch MJ, Wood DD. Reduction of serum interleukin 1-like activity after treatment with dexamethasone. J Leukocyte Biol 1985;37:193-207.
46. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-I receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990;343: 336-40.
47. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343:341-6.